Can SSRIs Cause Insomnia? What to Do About It

SSRIs can and frequently do cause insomnia. Research estimates that even during long-term treatment with activating antidepressants like fluoxetine, paroxetine, and sertraline, roughly 30 to 40 percent of patients continue to experience insomnia severe enough to need additional treatment. The relationship between SSRIs and sleep is more tangled than most people realize, because these same medications can also cause excessive drowsiness in some people, and the specific drug, dose, and your individual biology all shape which direction things go.

How Common the Problem Is, Drug by Drug

A large network meta-analysis published in Sleep in 2023 compared insomnia rates across 21 antidepressants during acute treatment for major depression. Every SSRI in the analysis carried a statistically higher risk of insomnia compared to placebo. Reboxetine topped the overall list at roughly three and a half times the odds, but among SSRIs specifically, sertraline, citalopram, and fluoxetine all landed in the range of about 1.5 to 1.7 times the odds of insomnia versus a sugar pill. Paroxetine and escitalopram showed somewhat lower but still meaningful increases.¹

What makes this confusing is that some of those same drugs also increase somnolence (daytime sleepiness). Paroxetine, for example, nearly tripled the odds of somnolence versus placebo in the same analysis, while also raising insomnia risk. Escitalopram did the same. So it is entirely possible for one person to feel knocked out by paroxetine and another person to lie awake at night on the same drug at the same dose. The overall pattern, though, is clear: SSRIs as a class tend to disrupt sleep more than they help it.¹

A separate head-to-head trial comparing fluoxetine, sertraline, and paroxetine found no significant difference between those three in terms of insomnia improvement or worsening. In other words, if you are already on one SSRI and it is keeping you up, switching to a different SSRI is unlikely to fix the sleep problem by itself.²

What SSRIs Do to Your Sleep

SSRIs raise serotonin levels in the brain, which is how they ease depression and anxiety. But serotonin is also deeply involved in regulating the sleep-wake cycle. Higher serotonin activity tends to promote wakefulness, which is why the clinical literature refers to drugs like fluoxetine and venlafaxine as “activating” antidepressants. That activation is exactly the problem at bedtime.³

Beyond simply making it harder to fall asleep, SSRIs alter what sleep researchers call sleep architecture. A review in Perspectives in Psychiatric Care concluded that SSRIs and serotonin-norepinephrine reuptake inhibitors (with the possible exception of escitalopram) disrupt sleep structure and decrease the amount of restorative deep sleep you get.⁴ That means even on nights when you manage to fall asleep, you may wake up feeling unrefreshed. The quality of sleep drops, not just the quantity.

This is an important distinction. Many people taking SSRIs report that they sleep a reasonable number of hours but still feel exhausted in the morning. That unrefreshing sleep often traces back to changes in deep sleep and REM patterns rather than simple trouble falling asleep.

Vivid Dreams, Nightmares, and Restless Legs

Insomnia is the most talked-about sleep side effect, but SSRIs can mess with sleep in other ways that are worth knowing about. One is a change in dreaming. SSRIs suppress REM sleep, the stage where most vivid dreaming occurs. Paradoxically, when the brain tries to compensate, it can produce unusually intense or disturbing dreams. A systematic review found that both the use and the withdrawal of SSRIs and SNRIs appear to intensify dreaming, and that a potential to cause nightmares should be factored into prescribing decisions.⁵

Another underrecognized issue is periodic limb movements during sleep, which are involuntary jerking or twitching motions of the legs (and sometimes arms) that can wake you up repeatedly without your realizing it. A meta-analysis found that SSRIs and venlafaxine produce a large effect on these movements, clearly exceeding the effect seen with other antidepressant classes.⁶ A separate systematic review noted that while some antidepressants may worsen restless legs syndrome, the effect for SSRIs like sertraline, fluoxetine, and amitriptyline tended to involve limb movements that did not significantly disrupt sleep in most patients. Mirtazapine and venlafaxine appeared to carry a somewhat higher risk of clinically meaningful leg-movement problems.⁷

If you have started an SSRI and notice that your legs feel restless at night, or a bed partner tells you that you kick in your sleep, it is worth mentioning to your doctor. This can be a treatable cause of fragmented sleep that often goes undiagnosed.

Who Is More Likely to Lose Sleep on an SSRI

Not everyone reacts the same way, and researchers have started looking at why. A study using genetic data from a large biobank found that people with a higher genetic predisposition to insomnia were more likely to report insomnia as a side effect from both escitalopram and amitriptyline. For amitriptyline, which is normally sedating, that genetic risk appeared to override the drug’s drowsiness-inducing effects, essentially canceling out what is supposed to be a sleep-promoting medication.⁸ This helps explain why two people can take the same SSRI and have completely opposite experiences with sleep.

Age and sex also matter. A study of older women living in the community found that those taking SSRIs were about four times as likely to take an hour or more to fall asleep and more than twice as likely to sleep five hours or less per night, even after the researchers adjusted for depression and other confounders.⁹ The fact that these sleep problems persisted after controlling for depression suggests the SSRIs themselves were the culprit, not just lingering mood symptoms.

Why This Side Effect Matters for Treatment Success

SSRI-related sleep disruption is not just an annoyance. It can undermine the very treatment it accompanies. A systematic review examining antidepressant side effects and medication adherence found that sleep-related side effects, including both somnolence and insomnia, were strongly linked to patients dropping out of treatment. One study within that review found that somnolence increased the odds of a patient stopping their SSRI more than eightfold.¹⁰

Poor sleep also worsens depression on its own. So an SSRI that treats your mood but wrecks your sleep can create a frustrating cycle: you feel less depressed during the day but too tired and irritable to function well, and the ongoing sleep deprivation chips away at the mood gains. This is one reason clinicians increasingly treat SSRI-related insomnia as a problem that needs its own intervention, rather than just telling patients to “give it a few weeks.”

What You Can Actually Do About It

If an SSRI is disrupting your sleep, there are several practical strategies, ranging from simple timing adjustments to adding a second medication or switching drugs entirely.

Adjust When You Take the Pill

The simplest first step is to take your SSRI in the morning rather than at bedtime, if you are not already doing so. Activating SSRIs like fluoxetine and sertraline are most likely to interfere with sleep when taken in the evening. This does not work for everyone, and some SSRIs (like paroxetine) can be mildly sedating for certain people, in which case evening dosing may actually help. But morning dosing is usually the lowest-effort change worth trying.

Cognitive Behavioral Therapy for Insomnia

CBT-I is a structured program that targets the thoughts and behaviors that perpetuate insomnia, things like lying in bed awake for hours, irregular sleep schedules, and anxiety about not sleeping. It is considered the first-line treatment for chronic insomnia regardless of cause. Research shows that combining antidepressant medication with CBT-I effectively alleviates insomnia symptoms in both adults and adolescents.¹¹ The advantage of CBT-I is that it addresses the sleep problem without adding another drug and its effects tend to last after the program ends.

CBT-I used to require weekly visits to a trained therapist, which limited access. Digital CBT-I programs delivered through apps and online platforms have now been shown to work well and are far easier to access. If your doctor suggests it, this is worth taking seriously rather than dismissing as “just sleep hygiene tips.” CBT-I goes well beyond the usual advice about avoiding screens before bed.

Adding a Sleep Medication

When behavioral approaches are not enough, a short-term sleep medication can help. Zolpidem (Ambien) has been specifically studied alongside SSRIs. In a randomized, controlled trial of patients with depression who had persistent insomnia while taking fluoxetine, sertraline, or paroxetine, adding zolpidem at 10 mg nightly led to longer sleep times, better sleep quality, fewer awakenings, and improved daytime functioning over four weeks compared to placebo.¹² A later analysis confirmed that the combination was both effective and safe in these patients.¹³

That said, zolpidem is not without risks, especially when combined with SSRIs. A case series flagged that people who metabolize drugs more slowly through certain liver enzymes may face a higher risk of serious side effects from zolpidem when it interacts pharmacologically with SSRIs or SNRIs.¹⁴ This does not mean the combination should be avoided across the board, but it is one reason your prescriber may start with a low dose and monitor you.

Low-dose trazodone is another commonly used add-on. Trazodone is technically an antidepressant, but at low doses (50 to 100 mg) it primarily acts as a sedative. It has a different mechanism from SSRIs and is widely prescribed off-label for insomnia. The trade-off is that trazodone can cause morning grogginess and, rarely, a prolonged painful erection (priapism) in men.

Switching to a Different Antidepressant

If insomnia persists despite adjustments, switching to a different antidepressant class may be the best move. Antidepressants with sedating properties, like mirtazapine, trazodone (at full antidepressant doses), and low-dose doxepin, tend to improve sleep rather than disrupt it.³ The caveat is that sedating antidepressants may cause their own long-term problems with oversedation, weight gain, or morning drowsiness.

Bupropion is sometimes suggested as a non-SSRI alternative that avoids serotonin-related side effects, but the 2023 network meta-analysis found that bupropion also raises insomnia risk at about 1.8 times placebo levels, so it is not a reliable swap if sleep is your primary concern.¹

Sleep Problems When Stopping an SSRI

It is worth knowing that sleep disruption can also show up when you stop or taper an SSRI, not just when you start one. A review of antidepressant withdrawal found that sleep disturbances are among the most common discontinuation symptoms, alongside dizziness, headache, and mood swings. Paroxetine and venlafaxine carry a higher risk of withdrawal effects, while fluoxetine, because of its very long half-life, tends to cause fewer problems with abrupt discontinuation. The general recommendation is to taper antidepressants over at least four weeks rather than stopping suddenly.¹⁵

Withdrawal-related sleep disruption can include intense or vivid dreams, rebound insomnia (sleep that is temporarily worse than it was before you started the medication), and general restlessness. The dreaming piece connects back to REM suppression: once the drug is removed, REM sleep rebounds dramatically, sometimes producing startlingly vivid or unpleasant dreams for days to weeks.⁵ A slow taper gives the brain time to readjust, which usually minimizes these effects.

The Persistence Problem

One of the most underappreciated aspects of SSRI-related insomnia is how long it can last. Many patients and clinicians assume that sleep disruption is an early side effect that fades within the first few weeks. For some people, that is exactly what happens. But data suggest the problem is far more persistent than often acknowledged. Even during maintenance treatment with activating antidepressants, an estimated 30 to 40 percent of patients still deal with insomnia and may need a co-prescribed sleep-promoting agent to manage it.³

This means the advice to “just wait it out” has real limits. If your SSRI-related insomnia has not improved after four to six weeks, it is reasonable to actively pursue one of the strategies above rather than simply hoping your body will adjust. The evidence supports treating the insomnia directly rather than tolerating it indefinitely, both because untreated insomnia can worsen depression and because it makes patients significantly more likely to stop taking their antidepressant altogether.

When the Insomnia Is Actually the Depression

Disentangling SSRI-caused insomnia from depression-related insomnia can be genuinely tricky, because insomnia is one of the most common symptoms of depression itself. About three-quarters of people with major depression report sleep problems, usually difficulty falling or staying asleep. So when someone starts an SSRI and has trouble sleeping, the question becomes: is this the drug, or is this the illness that has not yet responded to treatment?

A few clues help. If you slept reasonably well before starting the SSRI and the insomnia appeared within the first week or two of treatment, the drug is the most likely culprit. If your insomnia preceded the SSRI by weeks or months and the medication simply has not fixed it yet, the depression is more likely responsible. Some people experience both: their depression-related insomnia improves somewhat, but a new, different quality of wakefulness emerges from the medication. The study of older women referenced earlier is telling here, because it specifically controlled for depression severity and still found significantly worse sleep in the SSRI group, supporting the idea that the drugs have a direct sleep-disrupting effect independent of mood symptoms.⁹

Your prescriber can help sort this out by tracking how your sleep patterns change over time relative to your mood improvements. If your depression score is dropping but your sleep is getting worse, the medication is the most logical explanation, and it is worth addressing the insomnia on its own terms.

1
Sleep. Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis
2
PubMed. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia
3
PubMed Central. Effects of Antidepressants on Sleep
4
PubMed. Antidepressants and sleep: a review
5
PubMed. Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers
6
PubMed. Periodic leg movements during sleep associated with antidepressants: A meta-analysis
7
PubMed. The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review
8
PubMed Central. Understanding genetic risk factors for common side effects of antidepressant medications
9
PubMed Central. Use of selective serotonin reuptake inhibitors and sleep disturbances in community-dwelling older women
10
PubMed Central. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review
11
PubMed Central. Cognitive Behavioral Therapy for Insomnia in Depression
12
PubMed. Zolpidem for persistent insomnia in SSRI-treated depressed patients
13
PubMed Central. Effects of Approved Pharmacological Interventions for Insomnia on Mood Disorders: A Systematic Review
14
Journal of Pharmacy Practice and Research. Serious adverse drug reactions to zolpidem: does impaired metabolic clearance and concurrent SSRI/SNRI use increase risk?
15
PubMed Central. Antidepressant Withdrawal and Rebound Phenomena